Top Wall Street Forecasters Revamp Zoom Communications Price Expectations Ahead Of Q4 Earnings

Benzinga
02-24

Zoom Communications Inc. (NASDAQ:ZM) will release its fourth-quarter financial results, after the closing bell, on Monday, Feb. 24, 2025.

Analysts expect the San Jose, California-based company to report quarterly earnings at $1.35 per share, down from $1.42 per share in the year-ago period. Zoom projects quarterly revenue of $1.19 billion, compared to $1.15 billion a year earlier, according to data from Benzinga Pro.

On Nov. 25, Zoom reported third-quarter revenue of $1.18 billion, beating the consensus estimate of $1.16 billion. The communications company reported third-quarter adjusted earnings of $1.38 per share, beating analyst estimates of $1.31 per share.

Zoom shares fell 1.1% to close at $82.50 on Friday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • Citigroup analyst Tyler Radke maintained a Neutral rating and cut the price target from $86 to $85 on Feb. 18, 2025. This analyst has an accuracy rate of 72%.
  • Cantor Fitzgerald analyst Thomas Blakey initiated coverage on the stock with a Neutral rating and a price target of $87 on Jan. 16, 2025. This analyst has an accuracy rate of 71%.
  • Wells Fargo analyst Michael Turrin upgraded the stock from Underweight to Equal-Weight rating and raised the price target from $70 to $85 on Jan. 7, 2025. This analyst has an accuracy rate of 64%.
  • Morgan Stanley analyst Meta Marshall maintained an Equal-Weight rating and raised the price target from $86 to $96 on Dec. 18, 2024. This analyst has an accuracy rate of 75%.
  • Rosenblatt analyst Catharine Trebnick maintained a Buy rating and raised the price target from $78 to $95 on Nov. 26, 2024. This analyst has an accuracy rate of 79%.

Considering buying ZM stock? Here’s what analysts think:

Read This Next:

  • Top 2 Health Care Stocks That May Rocket Higher This Month

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10